Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Boehringer Ingelheim
AstraZeneca
Baxter
McKesson

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ELTROMBOPAG OLAMINE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

ELTROMBOPAG OLAMINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis PROMACTA KIT eltrombopag olamine FOR SUSPENSION;ORAL 207027 NDA Novartis Pharmaceuticals Corporation 0078-0972-61 1 CARTON in 1 KIT (0078-0972-61) > 30 PACKET in 1 CARTON (0078-0972-23) > 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0972-19)
Novartis PROMACTA eltrombopag olamine TABLET;ORAL 022291 NDA Novartis Pharmaceuticals Corporation 0078-0684-15 30 TABLET, FILM COATED in 1 BOTTLE (0078-0684-15)
Novartis PROMACTA eltrombopag olamine TABLET;ORAL 022291 NDA Novartis Pharmaceuticals Corporation 0078-0685-15 30 TABLET, FILM COATED in 1 BOTTLE (0078-0685-15)
Novartis PROMACTA eltrombopag olamine TABLET;ORAL 022291 NDA Novartis Pharmaceuticals Corporation 0078-0686-15 30 TABLET, FILM COATED in 1 BOTTLE (0078-0686-15)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Boehringer Ingelheim
Merck
McKesson
McKinsey